CompletedNCT00304187
Erythromycin or placebo for binge eating and digestion in bulimia
About this title
Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa
Read the official source — NCT00304187Medication studyAges 18–55United StatesEating disorders
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
What did participation involve?
Depending on the group, participants take erythromycin or placebo (an inactive comparison treatment) for six weeks.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateSeptember 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 29
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT00304187
- Official title
Show the full official title
Effects of Erythromycin on Binge Eating and GI Function in Bulimia Nervosa
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
What did participation involve?
The protocol called for participants to take study medication.
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Erythromycin and Placebo.
Who was this study for?
Listed age limits: 18 years to 55 years.
